CME activities, available through The Oncologist Online, are designed to change competence, performance and ultimately patient outcomes. All courses are approved for AMA PRA Category 1 Credit™ by the Society for Translational Oncology (STO).

STO, an ACCME accredited provider, supports its mission to speed the discovery and translation of important new treatments in the field of oncology to the practice of global oncology through its educational offerings. STO brings knowledge and strategies for critical new developments in cancer treatment into the practice environment of the community oncologist.

Register now to access complimentary CME!

Prostate Cancer: Progress and Promise

Roundtable Discussion: The Growing Complexity of Treatment Choices and Strategies

Drs. Chabner, Smith, Feldman, J. Efstathiou, E. Efstathiou, and Sartor

Roundtable Discussion: Part 2 – Belfast

Drs. Chabner, de Bono, O’Sullivan and Waugh

Emerging Understanding of Breast Cancer

The Biological Framework: Translational Research From Bench to Clinic

Yosef Yarden, PhD

Early-Stage Breast Cancer: Clinical Update

Chemotherapy: Updates and New Perspectives

Sandra M. Swain, M.D.

Hormone Receptor Positive Disease: New Developments

Martine J. Piccart-Gebhart, M.D., Ph.D

Changing Perceptions of Early-Stage Breast Cancer: Contributions from Histopathology and Biology

A New Look at Node-Negative Breast Cancer

Nadia Harbeck, M.D.

Changing Perceptions of Early-Stage Breast Cancer: Contributions from Histopathology and Biology

Molecular Stratification of Triple-Negative Breast Cancers

Charles M. Perou, PhD

Targeting Triple Negative Breast Cancer

Lisa A. Carey, M.D.

Coming of Age: Breast Cancer in Seniors

Hyman B. Muss, M.D.